Sinopharm
1099.HK
#1870
Rank
โ‚ฌ8.31 B
Marketcap
2,66ย โ‚ฌ
Share price
-0.23%
Change (1 day)
21.13%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): โ‚ฌ59.51 Billion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚ฌ77.23 Billion. In 2022 the company made a revenue of โ‚ฌ77.23 Billion a decrease over the revenue in the year 2021 that were of โ‚ฌ78.89 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚ฌ59.51 B-22.95%
2022 โ‚ฌ77.23 B-2.1%
2021โ‚ฌ78.89 B16.85%
2020โ‚ฌ67.51 B14.95%
2019โ‚ฌ58.73 B21.52%
2018โ‚ฌ48.33 B5.93%
2017โ‚ฌ45.62 B27.22%
2016โ‚ฌ35.86 B5.37%
2015โ‚ฌ34.03 B9.14%
2014โ‚ฌ31.18 B17.22%
2013โ‚ฌ26.60 B25.94%
2012โ‚ฌ21.12 B34.61%
2011โ‚ฌ15.69 B55.34%
2010โ‚ฌ10.10 B35.79%
2009โ‚ฌ7.43 B37.56%
2008โ‚ฌ5.40 B31.43%
2007โ‚ฌ4.11 B40.26%
2006โ‚ฌ2.93 B